Reversibility of stress-echo induced ST-segment depression by long-term oral n-3 PUFA supplementation in subjects with chest pain syndrome, normal wall motion at stress-echo and normal coronary angiogram

BMC Cardiovascular Disorders

Vigilio Ziacchi¹  Nicola Gaibazzi¹ 

[1] Cardiology Department, Ospedale Civile di Desenzano del Garda, Desenzano del Garda (BS), Italy

关键词: n-3 PUFA;    ST segment depression;    vasodilation;    stress;    microcirculation;    endothelium;    echocardiography;   

Others  :  1088608
DOI  :  10.1186/1471-2261-4-1

 received in 2003-11-07, accepted in 2004-03-23,  发布年份 2004

【 摘 要 】

Background

Normal coronary arteries may coexist with abnormal coronary and systemic endothelial function in patients with chest pain. Recent work by the renowned Pisa echo-group elegantly suggests that isolated ST-segment depression during stress-echo (SE) can be used as a marker of coronary endothelial dysfunction, in the absence of stress-inducible wall motion abnormalities and in the absence of angiographically-significant coronary artery disease (CAD). The long chain n-3 polyunsaturated fatty acids (PUFAs) have been reported to possess several properties that may positively influence vascular function. The present study's hypothesis is that a 4 month-course of oral supplementation with n-3 PUFAs can reverse endothelial dysfunction.

Methods

Subjects were selected on the basis of the following criteria: 1) reported chest pain syndrome, 2) significant ST-segment depression during an otherwise normal SE, 3) absence of angiographically-significant CAD. Subjects underwent a 4-month course of oral supplementation with commercially available n-3 PUFA, 1 g once a day. Normalization of endothelial dysfunction was defined, at the end of the supplementation period, by the absence of significant ST-segment depression during repeat SE. We tested the aforementioned hypothesis in a very small series of consecutive subjects, with the intent to produce a hypothesis-generating study.

Results

Seven out of the total nine subjects enrolled (77.8%) had normal ST-segment during repeat SE performed after the 4 month course of therapy.

Conclusions

A striking rate of reversion of SE-induced ST-segment depression after oral n-3 PUFAs suggests reversion of coronary endothelial dysfunction; nonetheless these data need to be validated in larger, placebo-controlled studies.

【 授权许可】

   
2004 Gaibazzi and Ziacchi; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 参考文献 】

• [1]Egashira K, Inou T, Hirooka , Yamada A, Urabe Y, Takeshita A: Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993, 328:1659-64.
• [2]Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC: Close relationship of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-41.
• [3]Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A: Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998, 82:1535-9.
• [4]Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111-15.
• [5]Palinkas A, Toth E, Amyot R, Rigo F, Venneri L, Picano E: The value of ECG and echocardiography during stress testing for identifying systemic endothelial dysfunction and epicardial artery stenosis. Eur Heart J 2002, 23(20):1587-95.
• [6]Preda I: Differentiation between endothelial dysfunction and epicardial coronary artery stenosis with the aid of stress ECG and echocardiography. A novel return of the old ECG! Eur Heart J 2002, 23(20):1561-2.
• [7]Ye D, Zhang D, Oltman C, Dellsperger K, Lee HC, VanRollins M: Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels. J Pharmacol Exp Ther 2002, 303(2):768-76.
• [8]Abeywardena MY, Head RJ: Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res 2001, 52(3):361-71.
• [9]Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico Lancet 1999, 354:447-55.
• [10]Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20 year mortality from coronary heart disease. N Engl J Med 1985, 312:1205-9.
• [11]Goode GK, Garcia S, Heagerty AM: Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 1997, 96:2802-7.
• [12]Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ: Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000, 35(2):265-70.
• [13]Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA: Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002, 106(6):653-8.